Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination

Clinical trial NCT02636855 · COMPLETED

Trial details

NCT number: NCT02636855
Sponsor: Adaptimmune
Status: COMPLETED
Study type: OBSERVATIONAL

Solid and Hematological Malignancies

Start date: 2015-12-01
Primary completion: 2024-06-28
Enrollment: 9122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.